These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 15755059)

  • 21. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.
    Salama JK; Mell LK; Schomas DA; Miller RC; Devisetty K; Jani AB; Mundt AJ; Roeske JC; Liauw SL; Chmura SJ
    J Clin Oncol; 2007 Oct; 25(29):4581-6. PubMed ID: 17925552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Concurrent chemoradiotherapy for squamous cell carcinoma of the anal canal-report of four cases].
    Kinjo A; Ogawa K; Iraha S; Tamaki W; Toita T; Kakinohana Y; Samura H; Kinjo I; Nishimaki T; Kuniyoshi Y; Murayama S
    Gan To Kagaku Ryoho; 2008 Mar; 35(3):519-22. PubMed ID: 18347409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of advanced anal cancer].
    Norum J; Wist E
    Nord Med; 1992; 107(8-9):227-8. PubMed ID: 1408730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of carcinoma anal canal with combination chemotherapy and concurrent radiotherapy.
    Mishra RC; Senapati S; Sai PL
    J Indian Med Assoc; 1996 Feb; 94(2):53-4, 57. PubMed ID: 8810177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anus-preservation treatment for anal cancer: retrospective analysis at a single institution.
    Chen YW; Yen SH; Chen SY; Huang PI; Shiau CY; Liu YM; Lin JK; Wang LW
    J Surg Oncol; 2007 Oct; 96(5):374-80. PubMed ID: 17492635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Node-negative T1-T2 anal cancer: radiotherapy alone or concomitant chemoradiotherapy?
    Zilli T; Schick U; Ozsahin M; Gervaz P; Roth AD; Allal AS
    Radiother Oncol; 2012 Jan; 102(1):62-7. PubMed ID: 21993403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Outcome of simultaneous radiochemotherapy of anal carcinoma].
    Fraunholz IB; Adamietz IA; Lorenz M; Staib-Sebler E; Böttcher HD
    Zentralbl Chir; 1997; 122(1):39-43. PubMed ID: 9133135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anal canal cancer treatment: practical limitations of routine prescription of concurrent chemotherapy and radiotherapy.
    Chauveinc L; Buthaud X; Falcou MC; Mosseri V; De la Rochefordière A; Pierga JY; Girodet J; Salmon RJ
    Br J Cancer; 2003 Dec; 89(11):2057-61. PubMed ID: 14647138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The prognostic factors following the simultaneous radiochemotherapy of anal canal carcinoma in a multicenter series of 139 patients].
    Grabenbauer GG; Panzer M; Hültenschmidt B; Döker R; Huber K; Kuhne-Velte HJ; Hutter M; Rühl U; Budach V; Wendt T
    Strahlenther Onkol; 1994 Jul; 170(7):391-9. PubMed ID: 8052938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elective inguinal node irradiation in early-stage T2N0 anal cancer: prognostic impact on locoregional control.
    Zilli T; Betz M; Bieri S; Ris F; Roche B; Roth AD; Allal AS
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):60-6. PubMed ID: 23608237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cancer of the anal canal].
    Ruíz Molina JM; Gómez Aceytuno R; Gallardo Rincón D; Herrera R; Mondragón Sánchez RJ; Oñate Ocaña LF; Aiello Crocifoglio V
    Rev Gastroenterol Mex; 1997; 62(3):184-8. PubMed ID: 9480525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of brachytherapy in the boost management of anal carcinoma with node involvement (CORS-03 study).
    Moureau-Zabotto L; Ortholan C; Hannoun-Levi JM; Teissier E; Cowen D; Salem N; Lemanski C; Ellis S; Resbeut M
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e135-42. PubMed ID: 23195780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients.
    Touboul E; Schlienger M; Buffat L; Lefkopoulos D; Pène F; Parc R; Tiret E; Gallot D; Malafosse M; Laugier A
    Cancer; 1994 Mar; 73(6):1569-79. PubMed ID: 8156483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of squamous cell anal canal carcinoma (SCACC) with pulsed dose rate brachytherapy: a retrospective study.
    Bruna A; Gastelblum P; Thomas L; Chapet O; Bollet MA; Ardiet JM; Gérard JP; Peiffert D
    Radiother Oncol; 2006 Apr; 79(1):75-9. PubMed ID: 16631268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anal carcinoma: prognostic value of endorectal ultrasound (ERUS). Results of a prospective multicenter study.
    Giovannini M; Bardou VJ; Barclay R; Palazzo L; Roseau G; Helbert T; Burtin P; Bouché O; Pujol B; Favre O
    Endoscopy; 2001 Mar; 33(3):231-6. PubMed ID: 11293755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Rationale and progress of the phase III trial: intensification of the treatment of locally advanced squamous cell carcinoma of the anal canal].
    Peiffert D
    Cancer Radiother; 2003 Nov; 7 Suppl 1():100s-107s. PubMed ID: 15124551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiotherapy and chemotherapy in the conservative treatment of anal canal carcinoma.
    Raffetto N; Monaco A; Banelli E
    Anticancer Res; 2008; 28(2B):1335-9. PubMed ID: 18505075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic role of p53 protein expression in epidermoid carcinoma of the anal canal.
    Wong CS; Tsao MS; Sharma V; Chapman WB; Pintilie M; Cummings BJ
    Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):309-14. PubMed ID: 10487550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
    Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
    J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients.
    Doci R; Zucali R; La Monica G; Meroni E; Kenda R; Eboli M; Lozza L
    J Clin Oncol; 1996 Dec; 14(12):3121-5. PubMed ID: 8955657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.